New data shows zigakibart sustains proteinuria remission and kidney function in IgA nephropathy
New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as...
shows
Hotter and drier climate in Colorado’s San Luis Valley contributes to kidney disease in agriculture workers, new study shows
Heat and humidity contributed to kidney damage and disease in the San Luis Valley in Colorado between 1984 and 1998,...
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with...
:quality(90) "New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis")
New England Journal of Medicine publishes new data for Roche’s Gazyva/Gazyvaro which shows superiority over standard therapy in people with active lupus nephritis
Nearly half of patients on Gazyva/Gazyvaro plus standard therapy achieved a complete renal response (CRR), with a statistically significant and...
Study shows tea consumption can lower mortality in chronic kidney disease
Tea consumption offers protective effects on mortality among patients with chronic kidney disease (CKD), according to a study published online...
30% of Albertans don’t visit the dentist regularly, data shows
Recent data from Statistics Canada suggests more than a million Albertans aren't getting in a dental chair for regular checkups. Only 70.9...
